BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9523141)

  • 1. Peritoneal washing in borderline epithelial ovarian tumors in women under 25: the use of cell block preparations.
    Gammon R; Hameed A; Keyhani-Rofagha S
    Diagn Cytopathol; 1998 Mar; 18(3):212-4. PubMed ID: 9523141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal washings in ovarian tumors. Potential sources of error in cytologic diagnosis.
    Covell JL; Carry JB; Feldman PS
    Acta Cytol; 1985; 29(3):310-6. PubMed ID: 3859128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytologic findings of psammocarcinoma in peritoneal washings.
    Pantanowitz L; Otis CN; Goulart RA
    Acta Cytol; 2009; 53(3):263-7. PubMed ID: 19534264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic washing cytology in serous borderline tumors of the ovary using ThinPrep: are there cytologic clues to detecting tumor cells?
    Sadeghi S; Ylagan LR
    Diagn Cytopathol; 2004 May; 30(5):313-9. PubMed ID: 15108228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serous surface carcinoma of the peritoneum: useful role of cytology in differential diagnosis and follow-up.
    Tauchi PS; Caraway N; Truong LD; Kaplan AL; Ramzy I
    Acta Cytol; 1996; 40(3):429-36. PubMed ID: 8669174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal cytology of uncommon ovarian tumors.
    Valente PT; Schantz HD; Edmonds PR; Hanjani P
    Diagn Cytopathol; 1992; 8(2):98-106. PubMed ID: 1314733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
    Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
    Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serous peritoneal papillary tumor of low malignancy potential. Report of a case].
    Mayerson D; Rondini C; Braun H; Chuaqui R; Brañes J
    Rev Med Chil; 2000 Feb; 128(2):206-10. PubMed ID: 10962890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian serous borderline tumors with noninvasive and invasive peritoneal implants: A case report each.
    Srinivasamurthy BC; Kulandai Velu AR; Krishnan N; Patil AS
    J Cancer Res Ther; 2015; 11(3):646. PubMed ID: 26458602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic pitfalls of peritoneal washing cytology and the role of cell blocks in their diagnosis.
    Selvaggi SM
    Diagn Cytopathol; 2003 Jun; 28(6):335-41. PubMed ID: 12768641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal involvement by salpingoliths clinical significance and cytological challenges of interpretation.
    El Hussein S; Guerrero D; Khader SN
    Diagn Cytopathol; 2019 Dec; 47(12):1302-1305. PubMed ID: 31390157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors.
    Burks RT; Sherman ME; Kurman RJ
    Am J Surg Pathol; 1996 Nov; 20(11):1319-30. PubMed ID: 8898836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodular histiocytic aggregates in the greater omentum of patients with ovarian cancer.
    Lv Y; Li P; Zheng J; Wang L; Yun J; Huang G; Yan Q; Li Z; Luo P; Li S; Harn L; Yi J; Wang Z
    Int J Surg Pathol; 2012 Apr; 20(2):178-84. PubMed ID: 22271884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grade 1 peritoneal serous carcinomas: a report of 14 cases and comparison with 7 peritoneal serous psammocarcinomas and 19 peritoneal serous borderline tumors.
    Weir MM; Bell DA; Young RH
    Am J Surg Pathol; 1998 Jul; 22(7):849-62. PubMed ID: 9669347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extraovarian peritoneal serous papillary carcinoma: an unusual surgical case].
    Meier C; Seifert M; Wehrli H
    Swiss Surg; 1999; 5(1):14-7. PubMed ID: 10073126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Borderline tumors of the ovary. Laparoscopic management?].
    Vargas JE; Mondion M; Wild R; López X
    Rev Chil Obstet Ginecol; 1993; 58(4):310-1. PubMed ID: 7991849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas.
    Ordóñez NG
    Am J Surg Pathol; 1998 Oct; 22(10):1203-14. PubMed ID: 9777982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinoma.
    Rubin SC; Dulaney ED; Markman M; Hoskins WJ; Saigo PE; Lewis JL
    Obstet Gynecol; 1988 Jun; 71(6 Pt 1):851-3. PubMed ID: 3285264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective comparative cytologic study of direct peritoneal smears and lavage fluids in patients with epithelial ovarian cancer and benign gynecologic disease.
    Luesley DM; Williams DR; Ward K; Redman CR; Lawton FG
    Acta Cytol; 1990; 34(4):539-44. PubMed ID: 2375222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
    Kennedy AW; Hart WR
    Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.